This might be similar to Nuclear factor-kappa B essential modulator (NEMO) deficiency due to IKBKG mutations, in which HSCT eliminates the increased susceptibility to recurrent/atypical infections, but does not cure the IBD phenotype (31). Here, IKBKG is linked to inflammatory bowel disease.